Decitabine and azacitidine exert multifaceted effects beyond DNA hypomethylation in myeloid neoplasms.

Yabushita T, Goyama S.

Open source

DOI
10.1007/s12185-026-04299-8
Published
2026-10-24
Container
Int J Hematol
Publisher
Not recorded
Open access
no

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1007/s12185-026-04299-8,
  title = {Decitabine and azacitidine exert multifaceted effects beyond DNA hypomethylation in myeloid neoplasms.},
  author = {Yabushita T and  Goyama S.},
  year = {2026},
  journal = {Int J Hematol},
  doi = {10.1007/s12185-026-04299-8},
  url = {https://doi.org/10.1007/s12185-026-04299-8}
}

RIS

TY  - JOUR
TI  - Decitabine and azacitidine exert multifaceted effects beyond DNA hypomethylation in myeloid neoplasms.
AU  - Yabushita T
AU  -  Goyama S.
PY  - 2026
JO  - Int J Hematol
DO  - 10.1007/s12185-026-04299-8
UR  - https://doi.org/10.1007/s12185-026-04299-8
ER  - 

APA

T, Y., & S., G. (2026). Decitabine and azacitidine exert multifaceted effects beyond DNA hypomethylation in myeloid neoplasms.. Int J Hematol. https://doi.org/10.1007/s12185-026-04299-8

Source records